- The Supreme Court has temporarily preserved access to mifepristone, a widely used abortion pill, by delaying a decision on potential restrictions until at least Thursday.
- Justice Samuel Alito issued the order, which effectively blocks a federal appeals court's imposed restrictions from taking immediate effect, allowing women to continue obtaining the medication through pharmacies or by mail.
- This legal challenge originates from a lawsuit filed by Louisiana, seeking to roll back the Food and Drug Administration’s established rules for prescribing mifepristone, despite the drug being deemed safe and effective by FDA scientists since its 2000 approval.
- Lower courts had previously concluded that Louisiana was likely to prevail, with a federal appeals court panel ruling that mail access and telehealth visits for mifepristone should be suspended.
- The dispute highlights the ongoing legal battles over abortion access in the U.S. following the overturning of Roe v. Wade, with medication abortions accounting for nearly two-thirds of all abortions in 2023.
IN FULL
